Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

NCT00002674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
DRUG: cytarabine
DRUG: etoposide
DRUG: hydroxyurea
DRUG: mitoxantrone hydrochloride
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]